EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Pharmacokinetics of Detomidine and Vatinoxan in Horses

B H Pypendop iD, M R Raekallio iD, N P Karikoski iD, N Hakonen iD, H A Tapio iD, L A Gracio Calvo iD, V M Rinne iD, J M Honkavaara iD

Journal of Veterinary Pharmacology and Therapeutics · 29.10.2026

DOI: 10.1111/jvp.70118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, online erschienen am 29.10.2026. Verfasst von B H Pypendop und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, Davis, California, USA. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Finnish Foundation for Veterinary Research, Vetcare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pharmacokinetics of detomidine, vatinoxan, and their combination have not been previously characterized in detail in horses. Detomidine (20 μg/kg), vatinoxan (200 μg/kg), or their combination was administered intravenously to six horses according to a Latin square design. Blood was sampled at various times up to 480 min following administration. Plasma concentrations of detomidine, OH‐detomidine, COOH‐detomidine, and vatinoxan were measured using liquid chromatography/tandem mass spectrometry. Compartmental models were fitted to the time‐concentration data using nonlinear mixed‐effect modeling. A 5‐compartment model provided the best fit for detomidine and its metabolites, whereas the disposition of vatinoxan was best described by a 3‐compartment model. The volume of distribution at steady state was 762 mL/kg for detomidine and 1422 mL/kg for vatinoxan. Total metabolic clearance was 21.6 mL/min/kg for detomidine and 7.1 mL/min/kg for vatinoxan. Clearance of detomidine into OH‐detomidine and of OH‐detomidine into COOH‐detomidine was predicted to be 40 and 7% of their respective clearance. Covariates accounting for the effect of vatinoxan on several parameters improved the model, suggesting that administration of vatinoxan affects the disposition of detomidine. Similarly, covariates suggested that administration of detomidine affects the disposition of vatinoxan.

Schlagwörter

Stichwörter der Autor:innen

alpha‐2 adrenergic receptor agonistalpha‐2 adrenergic receptor antagonistdetomidinehorsespharmacokineticsvatinoxan

Autor:innen und Institutionen

  • Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, Davis, California, USA.
  • Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland.
  • Faculty of Veterinary Medicine, Veterinary Teaching Hospital, University of Helsinki, Helsinki, Finland.
  • Admescope (Symeres Finland OY), Oulu, Finland.

ORCID-Profile: B H Pypendop, M R Raekallio, N P Karikoski, N Hakonen, H A Tapio, L A Gracio Calvo, V M Rinne, J M Honkavaara

Förderung

  • Finnish Foundation for Veterinary Research
  • Vetcare

Zitieren

APA

Pypendop, B. H., Raekallio, M. R., Karikoski, N. P., Hakonen, N., Tapio, H. A., Gracio Calvo, L. A., Rinne, V. M., & Honkavaara, J. M. (2026). Pharmacokinetics of Detomidine and Vatinoxan in Horses. Journal of Veterinary Pharmacology and Therapeutics. https://doi.org/10.1111/jvp.70118

Vancouver

Pypendop BH, Raekallio MR, Karikoski NP, Hakonen N, Tapio HA, Gracio Calvo LA, et al. Pharmacokinetics of Detomidine and Vatinoxan in Horses. Journal of Veterinary Pharmacology and Therapeutics. 2026. doi:10.1111/jvp.70118

BibTeX
@article{Pypendop2026,
  author = {Pypendop, B H and Raekallio, M R and Karikoski, N P and Hakonen, N and Tapio, H A and Gracio Calvo, L A and Rinne, V M and Honkavaara, J M},
  title = {Pharmacokinetics of Detomidine and Vatinoxan in Horses},
  journal = {Journal of Veterinary Pharmacology and Therapeutics},
  year = {2026},
  doi = {10.1111/jvp.70118}
}
Kostenlos starten →